Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what effects durvalumab has on bladder cancer,
combined with treatment after completion of surgery, chemotherapy and radiotherapy.